ABI
Adamant Biomedical Investments Portfolio holdings
AUM
$418M
This Quarter Return
+5.56%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$401M
AUM Growth
–
Cap. Flow
+$401M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
34.69%
Holding
96
New
96
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$20.9M |
| 2 |
CELG
Celgene Corp
CELG
|
$19.6M |
| 3 |
Biogen
BIIB
|
$18.2M |
| 4 |
Amgen
AMGN
|
$14M |
| 5 |
AGN
Allergan plc
AGN
|
$12.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 86.61% |
| 2 | Financials | 1.21% |
| 3 | Industrials | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
COV
26
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $5.19M | 1.3% |
+60,000
| New | +$5.19M |
|
|
QGENF
27
DELISTED
QIAGEN NV
QGENF
| $5.19M | 1.3% |
+250,610
| New | +$5.19M |
|
28
Eli Lilly
LLY
$650B
| $5.19M | 1.29% |
+80,000
| New | +$5.19M |
|
|
AET
29
DELISTED
Aetna Inc
AET
| $4.86M | 1.21% |
+60,000
| New | +$4.86M |
|
30
Johnson & Johnson
JNJ
$429B
| $4.8M | 1.2% |
+45,000
| New | +$4.8M |
|
31
Baxter International
BAX
$12.4B
| $4.67M | 1.16% |
+65,000
| New | +$4.67M |
|
32
Stryker
SYK
$149B
| $4.64M | 1.16% |
+57,500
| New | +$4.64M |
|
33
Humana
HUM
$37.4B
| $4.56M | 1.14% |
+35,000
| New | +$4.56M |
|
34
Elevance Health
ELV
$72.6B
| $4.55M | 1.13% |
+38,000
| New | +$4.55M |
|
35
Cigna
CI
$81.5B
| $4.54M | 1.13% |
+50,000
| New | +$4.54M |
|
36
Brookdale Senior Living
BKD
$1.84B
| $4.43M | 1.11% |
+137,620
| New | +$4.43M |
|
37
Dr. Reddy's Laboratories
RDY
$11.8B
| $4.2M | 1.05% |
+80,000
| New | +$4.2M |
|
38
Perrigo
PRGO
$3.27B
| $4.15M | 1.04% |
+30,750
| New | +$4.15M |
|
|
ESRX
39
DELISTED
Express Scripts Holding Company
ESRX
| $4.03M | 1% |
+57,000
| New | +$4.03M |
|
|
STJ
40
DELISTED
St Jude Medical
STJ
| $3.91M | 0.98% |
+65,000
| New | +$3.91M |
|
|
LCI
41
DELISTED
Lannett Company, Inc.
LCI
| $3.65M | 0.91% |
+80,000
| New | +$3.65M |
|
42
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.61M | 0.9% |
+50,000
| New | +$3.61M |
|
43
CVS Health
CVS
$94.4B
| $3.58M | 0.89% |
+45,000
| New | +$3.58M |
|
44
Incyte
INCY
$17.1B
| $3.43M | 0.86% |
+70,000
| New | +$3.43M |
|
45
Jazz Pharmaceuticals
JAZZ
$7.88B
| $3.21M | 0.8% |
+20,000
| New | +$3.21M |
|
46
HCA Healthcare
HCA
$95.4B
| $3.17M | 0.79% |
+45,000
| New | +$3.17M |
|
47
Insulet
PODD
$24.5B
| $2.95M | 0.74% |
+80,000
| New | +$2.95M |
|
48
ResMed
RMD
$40B
| $2.93M | 0.73% |
+59,450
| New | +$2.93M |
|
|
SHPG
49
DELISTED
Shire pic
SHPG
| $2.85M | 0.71% |
+11,000
| New | +$2.85M |
|
|
ENDP
50
DELISTED
Endo International plc
ENDP
| $2.73M | 0.68% |
+40,000
| New | +$2.73M |
|